Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Meridian Bioscience buys GenePOC

Executive Summary

Meridian Bioscience Inc. is acquiring Debiopharm Group’s GenePOC Inc. subsidiary for $50mm up front in cash and up to $20mm tied to development milestones in Meridian's FY 2021 and $50mm based on sales performance in 2023.
Deal Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register